The following research has been published in 2011-2012 using data or tissue specimens supplied by ABN-Oncology-affiliated tissue banks

  1. Ken Dutton-Regester, Darryl Irwin, Priscilla Hunt, Lauren Aoude, Varsha Tembe, Gulietta Pupo, Cathy Lanagan, Candace Carter, Linda O’Connor, Michael O’Rourke, Richard Scolyer, Graham Mann, Christopher Schmidt, Adrian Herington, and Nicholas Hayward (2012) A high throughput panel for identifying clinically-relevant mutation profiles in melanoma. Molecular Cancer Therapeutics, 11(4):888-97.
  2. Ken Dutton-Regester, Lauren Aoude, Derek J. Nancarrow, Mitchell S Stark, Linda O’Connor, Cathy Lanagan, Gulietta M. Pupo, Varsha Tembe, Candace D. Carter, Michael O’Rourke, Richard A. Scolyer, Graham Mann, Chris Schmidt, Adrian Herington, Nicholas K. Hayward. Identification of TFG (TRK fused gene) as a putative metastatic melanoma tumour suppressor gene. (2012) Genes, Chromosomes and Cancer 51(5):452-461
  3. Bonazzi VF, Nancarrow DJ, Stark MS, Moser RJ, Boyle GM, Aoude LG, Schmidt C, Hayward NK. (2011) Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1as Genes Frequently Silenced by Methylation in Melanoma. PLoS ONE 6(10): e26121. doi:10.1371/journal.pone.0026121
  4. Mitchell S. Stark, Susan L. Woods, Michael G. Gartside, Vanessa F. Bonazzi, Ken Dutton-Regester, Lauren G. Aoude, Donald Chow, Chris Sereduk, Natalie M. Niemi, Nanyun Tang, Jonathan J. Ellis, Jeffrey Reid, Victoria Zismann, Sonika Tyagi, Donna Muzny, Irene Newsham, YuanQing Wu, Jane M. Palmer, Thomas Pollak, David Youngkin, Bradford R. Brooks, Catherine Lanagan, Christopher W. Schmidt, Bostjan Kobe, Jeffrey P. MacKeigan, Hongwei Yin, Kevin M. Brown, Richard Gibbs, Jeffrey Trent, Nicholas K. Hayward. (2011) Frequent MAP3K5/9 somatic mutations in metastatic melanoma identified by exome sequencing. Nature Genetics, Dec 25;44(2):165-9
  5. Creaney J, Dick Ian M, Yeoman D, Wong S, Robinson BWS. Auto-antibodies to ß-F1-ATPase and Vimentin in Malignant Mesothelioma. PlosOne 2011 6:e26515.
  6. Creaney J, Segal A, Musk AW, Skates SJ, Robinson BWS. Mesothelioma Biomarkers- Now and the Future. Journal of Thoracic Oncology 2011 6: S4, 3
  7. Tan AL, Worku M, Davies HE, Mishra E, Sadler R, Creaney J, Lansley SM, Varano J, Karabela S, Stathopoulos G, Davies RJO, Lee YCG. Fibroblast growth Factor-9 is upregulated and may be involved in Mesothelioma Disease Pathobiology. Respirology 2011 16: S1, 13
  8. Arango D, Williams D, Al-Obaidi S, Dopeso J, Mazzolini R, Corner G, Byun D-S, Murone C, Togel L, Zeps N, Aaltonen L, Iacopetta B and Mariadason JM Am J Pathol. Villin expression is frequently lost in poorly differentiated colon cancer. 2012 Feb 17 [Epub ahead of print]
  9. Marianna J. Bledsoe, William E. Grizzle, Brian J. Clark Nikolajs Zeps Genet Med. Implementation Issues and Challenges for Biobanks in the Return of Individual Research Results. 2012 Feb 9.
  10. Chew A, Salama P, Robbshaw A, Klopcic B, Zeps N, Platell C, Lawrance IC PLoS OneSPARC, FOXP3, CD8 and CD45 Correlation with Disease Recurrence and Long-Term Disease-Free Survival in Colorectal Cancer 2011
  11. Joly Y, Zeps N, Knoppers BM.. Genomic databases access agreements: legal validity and possible sanctions. Human Genetics 2011 Vol 130 issue 3 pages 441-9
  12. Tonti-Filippini N, Zeps N. MJA Trade in human tissue products.2011 Vol194.Issue 5 263-5
  13. Xiang Guo, Qing-Rong Chen, Young K Song, Jun S Wei and Javed Khan.
    BMC Medical Genomics. Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status.
    2011 Volume 4 Issue 35.
  14. Loh M, Chua D, Yao Y, Soo RA, Garrett K, Zeps N, Platell C, Minamoto T, Kawakami K, Iacopetta B, Soong R.. Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies? Pharmacogenomics Journal. 2012.26
  15. Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D, Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM; Australian Pancreatic Cancer Genome Initiative, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA.
    The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
    Nature. 2012 Apr 29;486(7402):266-70. doi: 10.1038/nature11114.